| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000034299 |
| Receipt No. | R000038947 |
| Scientific Title | Feasibility study investigating the efficacy and safety of SOUTEN snare for colorectal endoscopic submucosal dissection |
| Date of disclosure of the study information | 2018/10/01 |
| Last modified on | 2020/09/28 (Ver. 5) |
| Basic information | ||
| Public title | Feasibility study investigating the efficacy and safety of SOUTEN snare for colorectal endoscopic submucosal dissection | |
| Acronym | Efficacy and safety of SOUTEN snare for colorectal endoscopic submucosal dissection | |
| Scientific Title | Feasibility study investigating the efficacy and safety of SOUTEN snare for colorectal endoscopic submucosal dissection | |
| Scientific Title:Acronym | Efficacy and safety of SOUTEN snare for colorectal endoscopic submucosal dissection | |
| Region |
|
|
| Condition | ||
| Condition | Colorectal adenoma/early colorectal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the safety and efficacy of SOUTEN snare for Colorectal ESD |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Complication rate
assessed after endoscopic treatment |
| Key secondary outcomes | Procedure time, The rate of adverse events (perforation, delayed bleeding)
|
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with colorectal adenoma/early cancer were consequentially enrolled in the present study. | |||
| Key exclusion criteria | Patients whose lesions were found to be outside the guideline or expanded criteria for ESD by the endoscopic characteristics and histological findings of biopsy specimens.
Patients in disagreement with informed consent |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | NTT Medical Center Tokyo | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 141-8625 | ||||||
| Address | 5-9-22 Higashi-gotanda Shinagawa-ku, Tokyo 141-8625, Japan | ||||||
| TEL | +81-3-3448-6111 | ||||||
| ken.ohata1974@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Omori Red Cross Hospital | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 143-8527 | ||||||
| Address | 4-30-1, Ohta-ku, Chuo, Tokyo | ||||||
| TEL | +81-3-3775-3111 | ||||||
| Homepage URL | |||||||
| junarimoto_junjun@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | NTT Medical Center Tokyo
Department of Gastroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | This study do not need financial support |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Omori Red Cross Hospital |
| Address | 4-30-1, Ohta-ku, Chuo, Tokyo |
| Tel | +81-3-3775-3111 |
| junarimoto_junjun@yahoo.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | NTT東日本関東病院(東京都)、大森赤十字病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi | ||||||
| Number of participants that the trial has enrolled | 119 | ||||||
| Results | Among 137 neoplasms, SOUTEN-ESD was completed in all cases. No cases required conversion to hybrid ESD or to a dedicated ESD device. The mean procedure time was about 26 minutes. The en-bloc resection rate was 100% and the R0 resection rate was 100%. The rate of perforation was 0%, the rate of delayed bleeding was 2.2%, and the rate of post-ESD coagulation syndrome (PECS) was 2.9%. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | From October 2018 to January 2019, 119 consecutive patients were prospectively enrolled and treated by SOUTEN-ESD. |
||||||
| Participant flow | Colorectal ESD was performed for 149 colorectal neoplasms at NTT Medical Center Tokyo and Omori Red Cross Hospital during the study period. We excluded 12 lesions (three lesions with huge polypoid growth, one lesion converging folds, four recurrent lesions after endoscopic treatment, and four lesions suspected of SM deeply invasive adenocarcinoma (SM deep invasion)) since we performed colorectal ESD with other knives. |
||||||
| Adverse events | The rate of perforation was 0%, the rate of delayed bleeding was 2.2% (3/137), and the rate of PECS was 2.9% (4/137). |
||||||
| Outcome measures | The rate of Failure of SOUTEN-ESD was 0% (The rate of complete SOUTEN-ESD was 100%). |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Observational study about usefulness of SOUTEN snare for colorectal ESD
This is a single arm study. The target lesion is adaptive lesion for conventional colorectal ESD |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038947 |